UY26156A1 - Aril y heteroaril pirimidonas policíclicas sustituidas útiles para la inhibición selectiva de la cascada de coagulación - Google Patents

Aril y heteroaril pirimidonas policíclicas sustituidas útiles para la inhibición selectiva de la cascada de coagulación

Info

Publication number
UY26156A1
UY26156A1 UY26156A UY26156A UY26156A1 UY 26156 A1 UY26156 A1 UY 26156A1 UY 26156 A UY26156 A UY 26156A UY 26156 A UY26156 A UY 26156A UY 26156 A1 UY26156 A1 UY 26156A1
Authority
UY
Uruguay
Prior art keywords
polycyclic
pirimidones
heteroaril
aril
selective inhibition
Prior art date
Application number
UY26156A
Other languages
English (en)
Inventor
Ashton Hamme
William Neumann
Darin Jones
Melvin L Rueppel
Michael S South
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of UY26156A1 publication Critical patent/UY26156A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se relaciona con compuestos de aril y heteroaril pirimidinonas policíclicas sustituidas útiles como inhibidores de las proteasas de la serina de la cascada de coagulación y compuestos, composiciones y métodos para la terapia anticoagulante en el tratamiento y prevención de distintas afecciones trombóticas incluyendo la enfermedad cerebro vascular y de las arterias coronarias.
UY26156A 1999-05-19 2000-05-19 Aril y heteroaril pirimidonas policíclicas sustituidas útiles para la inhibición selectiva de la cascada de coagulación UY26156A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13479499P 1999-05-19 1999-05-19

Publications (1)

Publication Number Publication Date
UY26156A1 true UY26156A1 (es) 2000-12-29

Family

ID=22465042

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26156A UY26156A1 (es) 1999-05-19 2000-05-19 Aril y heteroaril pirimidonas policíclicas sustituidas útiles para la inhibición selectiva de la cascada de coagulación

Country Status (22)

Country Link
EP (1) EP1178970A1 (es)
JP (1) JP2002544262A (es)
KR (1) KR20010114271A (es)
CN (1) CN1157380C (es)
AR (1) AR030021A1 (es)
AU (2) AU771718B2 (es)
BR (1) BR0010758A (es)
CA (1) CA2373614A1 (es)
CZ (1) CZ20014116A3 (es)
EA (1) EA004867B1 (es)
HU (1) HUP0201242A3 (es)
IL (1) IL146243A0 (es)
MX (1) MXPA01011804A (es)
NO (1) NO20015604L (es)
NZ (1) NZ514874A (es)
PE (1) PE20010229A1 (es)
PL (1) PL352827A1 (es)
SK (1) SK15852001A3 (es)
TW (1) TWI222445B (es)
UY (1) UY26156A1 (es)
WO (1) WO2000069832A1 (es)
ZA (2) ZA200109339B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750342B1 (en) 1999-05-19 2004-06-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6867217B1 (en) 1999-05-19 2005-03-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
US6458952B1 (en) 1999-05-19 2002-10-01 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6716838B1 (en) 1999-05-19 2004-04-06 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
AU771740B2 (en) * 1999-05-19 2004-04-01 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
US7015230B1 (en) 1999-05-19 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6653316B1 (en) 1999-05-19 2003-11-25 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6664255B1 (en) 1999-05-19 2003-12-16 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US6660885B2 (en) 2000-03-13 2003-12-09 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
EP1268428A2 (en) 2000-04-05 2003-01-02 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
DE60108948T2 (de) 2000-04-05 2005-11-03 Pharmacia Corp. Polyzyclisch aryl und heteroaryl substituierte 4-pyronen verwendbar als selektive hemmung von dem koagulationsprozess
CA2405684A1 (en) 2000-04-17 2001-10-25 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
AU2001222501A1 (en) * 2000-05-18 2001-11-26 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6710058B2 (en) 2000-11-06 2004-03-23 Bristol-Myers Squibb Pharma Company Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
US7015223B1 (en) 2000-11-20 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
US7119094B1 (en) 2000-11-20 2006-10-10 Warner-Lambert Company Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
JP2004517074A (ja) 2000-11-20 2004-06-10 ファルマシア・コーポレーション 凝血カスケードを選択的に阻害するのに有用な置換された多環アリールおよびヘテロアリールピリジン類
EP1438292A1 (en) 2001-10-03 2004-07-21 Pharmacia Corporation 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
CA2462647A1 (en) * 2001-10-03 2003-04-10 Michael S. South 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade
EP1432687A2 (en) 2001-10-03 2004-06-30 Pharmacia Corporation Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
AU2003215379A1 (en) * 2002-02-22 2003-09-09 Pharmacia And Upjohn Company Substituted pyrimidinones and pyrimidinthiones
TW200307667A (en) 2002-05-06 2003-12-16 Bristol Myers Squibb Co Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
US7217794B2 (en) 2003-04-02 2007-05-15 Daiamed, Inc. Compounds and methods for treatment of thrombosis
US7182738B2 (en) 2003-04-23 2007-02-27 Marctec, Llc Patient monitoring apparatus and method for orthosis and other devices
JP5002592B2 (ja) * 2005-06-07 2012-08-15 フアーマコペイア・インコーポレイテツド うつ病およびストレス疾患のためのアジノンおよびジアジノンｖ３阻害剤
CN104311537B (zh) * 2014-09-19 2016-08-24 广东东阳光药业有限公司 含有嘧啶酮乙酰基取代基吡唑类化合物及其组合物及用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441960A (en) * 1992-04-16 1995-08-15 Zeneca Limited 1-pyrimidinylacetamide human leukocyte elastate inhibitors
US5948785A (en) * 1995-04-27 1999-09-07 The Green Cross Corporation Heterocyclic amide compounds and pharmaceutical use of the same

Also Published As

Publication number Publication date
CN1351593A (zh) 2002-05-29
AR030021A1 (es) 2003-08-13
WO2000069832A1 (en) 2000-11-23
CN1157380C (zh) 2004-07-14
AU771718B2 (en) 2004-04-01
MXPA01011804A (es) 2003-09-04
HUP0201242A2 (hu) 2002-12-28
JP2002544262A (ja) 2002-12-24
EA200101214A1 (ru) 2002-06-27
BR0010758A (pt) 2003-06-10
NO20015604L (no) 2002-01-11
AU4973400A (en) 2000-12-05
TWI222445B (en) 2004-10-21
IL146243A0 (en) 2002-07-25
PE20010229A1 (es) 2001-03-07
AU2004202375A1 (en) 2004-06-24
NZ514874A (en) 2004-11-26
CZ20014116A3 (cs) 2002-06-12
EP1178970A1 (en) 2002-02-13
KR20010114271A (ko) 2001-12-31
EA004867B1 (ru) 2004-08-26
ZA200109339B (en) 2004-05-26
ZA200400448B (en) 2004-09-29
NO20015604D0 (no) 2001-11-16
SK15852001A3 (sk) 2003-06-03
CA2373614A1 (en) 2000-11-23
HUP0201242A3 (en) 2003-02-28
PL352827A1 (en) 2003-09-08

Similar Documents

Publication Publication Date Title
UY26156A1 (es) Aril y heteroaril pirimidonas policíclicas sustituidas útiles para la inhibición selectiva de la cascada de coagulación
UY26154A1 (es) Aril y heteroaril piridonas policíclicas sustituidas útiles para la inhibición selectiva de la cascada de coagulación
BR0011273A (pt) Uracilas de heteroarila e arila policìclica substituìdas como agentes anti-coagulantes
UY26155A1 (es) Aril y heteroaril pirazinonas policiclicas sustituidas útiles para la inhibición selectiva de la cascada de coagulación.
ATE544748T1 (de) Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen
DE60335743D1 (de) Verbindungen und verfahren zur erhöhung der neurogenese
ATE444960T1 (de) Polyhydroxystilbene und -stilbenoxide als antipsoriasismittel und proteinkinasehemmer
ATE497495T1 (de) Zur behandlung von neoplastischen erkrankungen, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4- di(phenylamino)pyrimidine
ATE320426T1 (de) Harnstoffderivate und ihre verwendung
ATE407676T1 (de) Topoisomerasehemmern zur behandlung von chirurgischen verklebungen
DK1278748T3 (da) Inhibitorer af human phosphatidyl-inositol 3-kinase delta
DK1754707T3 (da) Multicykliske forbindelser og anvendelse deraf som inhibitorer af PARP-, VEGFR2- og MLK3-enzymer
ME00145B (me) Upotreba supstituisanih jedinjenja azetidinona za lečenje sitosterolemije
PT1115701E (pt) Ureias de arilsulfonanilida
UY27774A1 (es) Inhibidores de metaloproteinas de triaril-oxi-aril-espiropirimidina-2,4,6-triona
PL375204A1 (en) Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
ATE240328T1 (de) Substituierte azaoxindolederivate
ATE389651T1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
DE60008540D1 (de) Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen
ATE367380T1 (de) Zur behandlung von zns-erkrankungen geeignete piperazinylchinolinderivate
PT1268463E (pt) 4-pironas substituidas com arilo e heteroarilo policiclicos uteis para a inibicao selectiva da cascata de coagulacao
ES2189165T3 (es) Nuevos compuestos macrociclicos como inhibidores de metaloproteasa.
ATE435649T1 (de) 4-brom-5-(2-chlor-benzoylamino)-1h-pyrazol-3- carbonsäure(phenyl)amid-derivate und verwandte verbindungen als bradykinin b1 receptor antagonisten zur behandlung von entzündlichen erkrankungen
ATE365732T1 (de) Pyrimidine als inhibitoren von phosphoinositid-3- kinasen (pi3k)
DK1226819T3 (da) Inhibitor for 20-HETE-producerende enzym

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20101022